Literature DB >> 15787094

Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype.

Aihua Li1, Michelle L Varney, Rakesh K Singh.   

Abstract

The purpose of this study was to examine the expression and functional significance of the growth-regulated oncogene (gro) family in human colon carcinoma growth and metastasis. We examined constitutive expression of CXCL1 (gro-alpha), CXCL2 (gro-beta), CXCL3 (gro-gamma) and their receptor, CXCR2 in human colon carcinoma cells with different metastatic potentials. Non-metastatic and low metastatic cells expressed lower levels of CXCL1 and CXCR2 mRNA and protein as compared to high metastatic colon carcinoma cells. No difference in CXCL2 and CXCL3 mRNA expression levels was observed. Colon carcinoma cells expressing higher levels of CXCL1 exhibit increased proliferation and invasive potential. Furthermore, exogenous addition of recombinant human CXCL1 significantly enhanced the proliferation and invasiveness of colon carcinoma cells. Furthermore, treatment of KM12C cells with exogenous CXCL1 enhanced their invasiveness. Neutralizing antibody to CXCL1 in combination with antibody to CXCR2 inhibited highly metastatic KM12L4 (high CXCL1 expressor) cell proliferation. These data demonstrate that the constitutive expression of CXCL1 and its receptor CXCR2 is associated with metastatic potential and modulates colon cancer cell proliferation and an invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15787094     DOI: 10.1007/s10585-004-5458-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Cxc chemokine receptor expression on human endothelial cells.

Authors:  C Murdoch; P N Monk; A Finn
Journal:  Cytokine       Date:  1999-09       Impact factor: 3.861

2.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

3.  Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.

Authors:  A Li; M L Varney; R K Singh
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

4.  Carcinoma-cells express IL-8 and the IL-8 receptor - their inhibition attenuates the growth of carcinoma-cells.

Authors:  T Ishiko; K Sakamoto; S Yamashita; Y Masuda; H Kamohara; S Mita; M Hirashima; M Ogawa
Journal:  Int J Oncol       Date:  1995-01       Impact factor: 5.650

5.  Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.

Authors:  E Loukinova; G Dong; I Enamorado-Ayalya; G R Thomas; Z Chen; H Schreiber; C Van Waes
Journal:  Oncogene       Date:  2000-07-20       Impact factor: 9.867

6.  Recombinant expression, biochemical characterization, and biological activities of the human MGSA/gro protein.

Authors:  E Balentien; J H Han; H G Thomas; D Z Wen; A K Samantha; C O Zachariae; P R Griffin; R Brachmann; W L Wong; K Matsushima
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

7.  Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro.

Authors:  A J Wilson; K Byron; P R Gibson
Journal:  Clin Sci (Lond)       Date:  1999-09       Impact factor: 6.124

8.  Regulation of interleukin 8 expression in human malignant melanoma cells.

Authors:  R K Singh; M L Varney
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

9.  Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.

Authors:  D P Cerretti; C J Kozlosky; T Vanden Bos; N Nelson; D P Gearing; M P Beckmann
Journal:  Mol Immunol       Date:  1993-03       Impact factor: 4.407

10.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

View more
  36 in total

1.  Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.

Authors:  Michelle L Varney; Seema Singh; Aihua Li; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Cancer Lett       Date:  2010-10-29       Impact factor: 8.679

2.  Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.

Authors:  Janice E Drew; Claus-Dieter Mayer; Andrew J Farquharson; Pauline Young; Lawrence N Barrera
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).

Authors:  Silke Cameron; Marieke Gieselmann; Martina Blaschke; Giuliano Ramadori; Laszlo Füzesi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.

Authors:  Ke-Qi Han; Xue-Qun He; Meng-Yu Ma; Xiao-Dong Guo; Xue-Min Zhang; Jie Chen; Hui Han; Wei-Wei Zhang; Quan-Gang Zhu; Hua Nian; Li-Jun Ma
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.

Authors:  Sajjad Khan; Silke Cameron; Martina Blaschke; Federico Moriconi; Naila Naz; Ahmad Amanzada; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

6.  Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

Authors:  Tsuyoshi Yoshida; Takumi Kobayashi; Masaya Itoda; Taika Muto; Ken Miyaguchi; Kaoru Mogushi; Satoshi Shoji; Kazuro Shimokawa; Satoru Iida; Hiroyuki Uetake; Toshiaki Ishikawa; Kenichi Sugihara; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  Cancer Inform       Date:  2010-07-29

7.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

8.  High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis.

Authors:  Anguraj Sadanandam; Michelle L Varney; Seema Singh; Abdelkader E Ashour; Nicolas Moniaux; Shonali Deb; Subodh M Lele; Surinder K Batra; Rakesh K Singh
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

9.  RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

Authors:  Pamela K Kreeger; Roli Mandhana; Shannon K Alford; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

10.  Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

Authors:  Brian Bierie; Christine H Chung; Joel S Parker; Daniel G Stover; Nikki Cheng; Anna Chytil; Mary Aakre; Yu Shyr; Harold L Moses
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.